Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.51
-0.12 (-1.57%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $375.14 million as of February 21, 2025. Its market cap has decreased by -7.02% in one year.
Market Cap
375.14M
Enterprise Value
219.84M
1-Year Change
-7.02%
Ranking
Category
Stock Price
$7.51
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $375.14M, a decrease of -5.68%. That is a compound annual growth rate of -1.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 375.14M | -8.64% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |